Catalyst Pharmaceuticals (CPRX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Catalyst Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$588.99M

Latest Revenue (Q)

$146.56M

Main Segment (Y)

Product Revenue Net

Main Geography (Y)

Non-US

Catalyst Pharmaceuticals Revenue by Period

Catalyst Pharmaceuticals Revenue by Year

Date	Revenue	Change
2025-12-31	$588.99M	19.78%
2024-12-31	$491.73M	23.49%
2023-12-31	$398.20M	85.90%
2022-12-31	$214.20M	52.10%
2021-12-31	$140.83M	18.27%
2020-12-31	$119.07M	16.39%
2019-12-31	$102.31M	20361.20%
2018-12-31	$500.00K	100.00%
2017-12-31	-	100.00%
2016-12-31	-	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	100.00%
2011-12-31	-	-100.00%
2010-12-31	$488.96K	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	100.00%
2005-12-31	-	100.00%
2004-12-31	-	100.00%
2003-12-31	-	100.00%
2002-12-31	-	-

Catalyst Pharmaceuticals generated $588.99M in revenue during NA 2025, up 19.78% compared to the previous quarter, and up 494.65% compared to the same period a year ago.

Catalyst Pharmaceuticals Revenue by Quarter

Date	Revenue	Change
2025-06-30	$146.56M	3.64%
2025-03-31	$141.42M	-0.28%
2024-12-31	$141.82M	10.20%
2024-09-30	$128.69M	4.88%
2024-06-30	$122.71M	24.57%
2024-03-31	$98.51M	-10.91%
2023-12-31	$110.57M	7.67%
2023-09-30	$102.69M	3.12%
2023-06-30	$99.58M	16.65%
2023-03-31	$85.37M	40.50%
2022-12-31	$60.76M	6.14%
2022-09-30	$57.24M	7.78%
2022-06-30	$53.11M	23.26%
2022-03-31	$43.09M	12.48%
2021-12-31	$38.31M	6.55%
2021-09-30	$35.95M	-1.13%
2021-06-30	$36.37M	20.39%
2021-03-31	$30.20M	-2.61%
2020-12-31	$31.01M	5.79%
2020-09-30	$29.32M	-0.97%
2020-06-30	$29.60M	1.61%
2020-03-31	$29.14M	-3.27%
2019-12-31	$30.12M	-2.51%
2019-09-30	$30.90M	7.14%
2019-06-30	$28.84M	131.66%
2019-03-31	$12.45M	2389.69%
2018-12-31	$500.00K	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	100.00%
2017-12-31	-	100.00%
2017-09-30	-	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	-100.00%
2010-12-31	$488.96K	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Catalyst Pharmaceuticals generated $146.56M in revenue during Q2 2025, up 3.64% compared to the previous quarter, and up 148.78% compared to the same period a year ago.

Catalyst Pharmaceuticals Revenue Breakdown

Catalyst Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Product Revenue Net	$588.81M	$489.33M	$396.50M	$213.94M	$138.00M
License And Other Revenue	$182.00K	$2.41M	$1.70M	$265.00K	$2.84M

Catalyst Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product Revenue Net (99.97%), and License And Other Revenue (0.03%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
Product Revenue Net	$152.50M	$148.37M	$146.54M	$141.40M	$264.46M	$126.42M	$98.44M	$109.10M	$102.62M	$99.48M	$85.30M	$60.68M	$57.17M	$53.05M	$43.03M	$38.27M	-	-
License And Other Revenue	$111.00K	$27.00K	$23.00K	$21.00K	$68.00K	$2.27M	$68.00K	$1.46M	$71.00K	$105.00K	$62.00K	$74.00K	$71.00K	$64.00K	$56.00K	-	-	-
Product Revenue, Net	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$35.89M	$33.64M

Catalyst Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product Revenue Net (99.93%), and License And Other Revenue (0.07%).

Catalyst Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 20
Non-US	$2.30M	-
CANADA	-	$33.00K

Catalyst Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 25: Non-US (100.00%).

Quarterly Revenue by Country

Country	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
License And Other Revenue	$105.00K	$62.00K	$74.00K	$71.00K	$64.00K	$56.00K	-	-	-
Product Revenue Net	$99.48M	$85.30M	$60.68M	$57.17M	$53.05M	$43.03M	$38.27M	-	-
Product Revenue, Net	-	-	-	-	-	-	-	$35.89M	$33.64M

Catalyst Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Jun 23: Product Revenue Net (99.89%), and License And Other Revenue (0.11%).

Catalyst Pharmaceuticals Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
APLS	Apellis Pharmaceuticals	$689.38M	$177.75M
KNSA	Kiniksa Pharmaceuticals	$677.56M	$180.85M
CPRX	Catalyst Pharmaceuticals	$588.99M	$146.56M
ADPT	Adaptive Bio	$276.98M	$58.88M
IDYA	IDEAYA Biosciences	$218.71M	$207.83M
RXRX	Recursion Pharmaceuticals	$74.68M	$5.17M
AGIO	Agios Pharmaceuticals	$54.03M	$12.88M
CDTX	Cidara Therapeutics	$1.27M	-
MLYS	Mineralys Therapeutics	-	-
SRRK	Scholar Rock	-	-
BEAM	Beam Therapeutics	-	-

CPRX Revenue FAQ

What is Catalyst Pharmaceuticals’s yearly revenue?

Catalyst Pharmaceuticals's yearly revenue for 2025 was $588.99M, representing an increase of 19.78% compared to 2024. The company's yearly revenue for 2024 was $491.73M, representing an increase of 23.49% compared to 2023. CPRX's yearly revenue for 2023 was $398.2M, representing an increase of 85.90% compared to 2022.

What is Catalyst Pharmaceuticals’s quarterly revenue?

Catalyst Pharmaceuticals's quarterly revenue for Q2 2025 was $146.56M, a 3.64% increase from the previous quarter (Q1 2025), and a 19.44% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $141.42M, a -0.28% decrease from the previous quarter (Q4 2024), and a 43.56% increase year-over-year (Q1 2024). CPRX's quarterly revenue for Q4 2024 was $141.82M, a 10.20% increase from the previous quarter (Q3 2024), and a 28.26% increase year-over-year (Q4 2023).

What is Catalyst Pharmaceuticals’s revenue growth rate?

Catalyst Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 47.91%, and for the last 5 years (2021-2025) was 318.22%.

What are Catalyst Pharmaceuticals’s revenue streams?

Catalyst Pharmaceuticals's revenue streams in c 25 are Product Revenue Net, and License And Other Revenue. Product Revenue Net generated $588.81M in revenue, accounting 99.97% of the company's total revenue, up 20.33% year-over-year. License And Other Revenue generated $182K in revenue, accounting 0.03% of the company's total revenue, down -92.44% year-over-year.

What is Catalyst Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Catalyst Pharmaceuticals was Product Revenue Net. This segment made a revenue of $588.81M, representing 99.97% of the company's total revenue.